BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29914080)

  • 1. Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases.
    Selvan LDN; Danda R; Madugundu AK; Puttamallesh VN; Sathe GJ; Krishnan UM; Khetan V; Rishi P; Prasad TSK; Pandey A; Krishnakumar S; Gowda H; Elchuri SV
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29914080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
    Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
    Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells.
    Abe J; Zhou W; Takuwa N; Taguchi J; Kurokawa K; Kumada M; Takuwa Y
    Cancer Res; 1994 Jul; 54(13):3407-12. PubMed ID: 8012959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
    Zhang K; Kumar R
    Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human retinoblastoma protein (Rb) is phosphorylated by cdc2 kinase and MAP kinase in Xenopus maturing oocytes.
    Taieb F; Karaiskou A; Rime H; Jessus C
    FEBS Lett; 1998 Apr; 425(3):465-71. PubMed ID: 9563514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-purification of p34cdc2/p58cyclin A proline-directed protein kinase and the retinoblastoma tumor susceptibility gene product: interaction of an oncogenic serine/threonine protein kinase with a tumor-suppressor protein.
    Williams RT; Carbonaro-Hall DA; Hall FL
    Oncogene; 1992 Mar; 7(3):423-32. PubMed ID: 1532245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential cyclin-dependent kinase expression and activation in human colon cancer.
    Salh B; Bergman D; Marotta A; Pelech SL
    Anticancer Res; 1999; 19(1B):741-8. PubMed ID: 10216486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear phosphoproteome analysis of 3T3-L1 preadipocyte differentiation reveals system-wide phosphorylation of transcriptional regulators.
    Rabiee A; Schwämmle V; Sidoli S; Dai J; Rogowska-Wrzesinska A; Mandrup S; Jensen ON
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 27717184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the retinoblastoma protein by cdk2.
    Akiyama T; Ohuchi T; Sumida S; Matsumoto K; Toyoshima K
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7900-4. PubMed ID: 1518810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
    Timchenko NA; Wilde M; Iakova P; Albrecht JH; Darlington GJ
    Nucleic Acids Res; 1999 Sep; 27(17):3621-30. PubMed ID: 10446255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein.
    Fagan R; Flint KJ; Jones N
    Cell; 1994 Sep; 78(5):799-811. PubMed ID: 8087847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
    Strobeck MW; Fribourg AF; Puga A; Knudsen ES
    Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of Keratin-8 in skin squamous cell carcinoma derived cell line.
    Tiwari R; Sahu I; Soni BL; Sathe GJ; Datta KK; Thapa P; Sinha S; Vadivel CK; Dhaka B; Gowda H; Vaidya MM
    Proteomics; 2017 Apr; 17(7):. PubMed ID: 28176443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced apoptosis mediated by retinoblastoma protein.
    Bowen C; Spiegel S; Gelmann EP
    Cancer Res; 1998 Aug; 58(15):3275-81. PubMed ID: 9699655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.
    Zhang HS; Gavin M; Dahiya A; Postigo AA; Ma D; Luo RX; Harbour JW; Dean DC
    Cell; 2000 Mar; 101(1):79-89. PubMed ID: 10778858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
    Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
    Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subtyping of cancer and nomination of kinase candidates for inhibition with phosphoproteomics: Reanalysis of CPTAC ovarian cancer.
    Tong M; Yu C; Zhan D; Zhang M; Zhen B; Zhu W; Wang Y; Wu C; He F; Qin J; Li T
    EBioMedicine; 2019 Feb; 40():305-317. PubMed ID: 30594550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.